Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells

Hideko Akagi, Hajime Higuchi, Hidetoshi Sumimoto, Toru Igarashi, Ayano Kabashima, Hiroyuki Mizuguchi, Motoko Izumiya, Gen Sakai, Masayuki Adachi, Shinsuke Funakoshi, Shoko Nakamura, Yasuo Hamamoto, Takanori Kanai, Hiromasa Takaishi, Yutaka Kawakami, Toshifumi Hibi

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Background: Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic protein that regulates apoptosis sensitivity in a variety of cell types. Here we evaluate the roles of Mcl-1 in chemotherapy-associated apoptosis in gastric cancer cells. In addition, our study examined whether Mcl-1 contributed to apoptosis resistance in so-called cancer stem cell (CSC)-like populations in gastric cancer. Methods: Seven gastric cancer cell lines were used. The expression of Mcl-1 was assessed by either real-time polymerase chain reaction or Western blot analysis. Apoptosis was quantitated by morphological observation and caspase activity measurement. Adenovirus-mediated RNA interference (RNAi) technology was used to knockdown the expression of Mcl-1. The release of cytochrome c was evaluated by subcellular fractionation and immunoblot analysis. To identify and isolate the CSC-like populations, we used the CSC-associated cell surface marker CD44 and flow cytometry. Results: Six out of the 7 gastric cancer cell lines overexpressed Mcl-1 protein. These Mcl-1-expressing cell lines were relatively resistant to chemotherapeutic agents such as 5-fluorouracil (5-FU) and cisplatin (CDDP). Depletion of Mcl-1 protein by RNAi technology effectively sensitized the cells to anticancer drug-induced mitochondrial cytochrome c release, caspase activation, and apoptosis. In addition, vast amounts of Mcl-1 mRNA were expressed in CD44-positive CSC-like cells. Mcl-1 suppression enhanced the apoptosis in CD44-positive cells to a level equivalent to that in CD44-negative cells, suggesting that Mcl-1 mediates chemotherapy resistance in CSC-like populations. Conclusion: These results suggest that Mcl-1 mediates the resistance to apoptosis in gastric cancer cells by blocking the mitochondrial pathway of cell death. Mcl-1 depletion appears to be an attractive strategy to overcome chemotherapy resistance in gastric cancer cells.

Original languageEnglish
Pages (from-to)100-110
Number of pages11
JournalGastric Cancer
Volume16
Issue number1
DOIs
Publication statusPublished - 2013 Jan

Fingerprint

Myeloid Leukemia
Myeloid Cells
Stomach Neoplasms
Apoptosis
Drug Therapy
Neoplastic Stem Cells
Caspases
RNA Interference
Cytochromes c
Cell Line
Population
Technology
Apoptosis Regulatory Proteins
Adenoviridae
Fluorouracil
Cisplatin
Real-Time Polymerase Chain Reaction
Flow Cytometry
Proteins
Cell Death

Keywords

  • Apoptosis
  • Cancer stem cell
  • CD44
  • Chemotherapy resistance

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Cancer Research

Cite this

Akagi, H., Higuchi, H., Sumimoto, H., Igarashi, T., Kabashima, A., Mizuguchi, H., ... Hibi, T. (2013). Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer, 16(1), 100-110. https://doi.org/10.1007/s10120-012-0153-6

Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. / Akagi, Hideko; Higuchi, Hajime; Sumimoto, Hidetoshi; Igarashi, Toru; Kabashima, Ayano; Mizuguchi, Hiroyuki; Izumiya, Motoko; Sakai, Gen; Adachi, Masayuki; Funakoshi, Shinsuke; Nakamura, Shoko; Hamamoto, Yasuo; Kanai, Takanori; Takaishi, Hiromasa; Kawakami, Yutaka; Hibi, Toshifumi.

In: Gastric Cancer, Vol. 16, No. 1, 01.2013, p. 100-110.

Research output: Contribution to journalArticle

Akagi, H, Higuchi, H, Sumimoto, H, Igarashi, T, Kabashima, A, Mizuguchi, H, Izumiya, M, Sakai, G, Adachi, M, Funakoshi, S, Nakamura, S, Hamamoto, Y, Kanai, T, Takaishi, H, Kawakami, Y & Hibi, T 2013, 'Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells', Gastric Cancer, vol. 16, no. 1, pp. 100-110. https://doi.org/10.1007/s10120-012-0153-6
Akagi, Hideko ; Higuchi, Hajime ; Sumimoto, Hidetoshi ; Igarashi, Toru ; Kabashima, Ayano ; Mizuguchi, Hiroyuki ; Izumiya, Motoko ; Sakai, Gen ; Adachi, Masayuki ; Funakoshi, Shinsuke ; Nakamura, Shoko ; Hamamoto, Yasuo ; Kanai, Takanori ; Takaishi, Hiromasa ; Kawakami, Yutaka ; Hibi, Toshifumi. / Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. In: Gastric Cancer. 2013 ; Vol. 16, No. 1. pp. 100-110.
@article{d12792c7017245d9a5497cee5adfd258,
title = "Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells",
abstract = "Background: Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic protein that regulates apoptosis sensitivity in a variety of cell types. Here we evaluate the roles of Mcl-1 in chemotherapy-associated apoptosis in gastric cancer cells. In addition, our study examined whether Mcl-1 contributed to apoptosis resistance in so-called cancer stem cell (CSC)-like populations in gastric cancer. Methods: Seven gastric cancer cell lines were used. The expression of Mcl-1 was assessed by either real-time polymerase chain reaction or Western blot analysis. Apoptosis was quantitated by morphological observation and caspase activity measurement. Adenovirus-mediated RNA interference (RNAi) technology was used to knockdown the expression of Mcl-1. The release of cytochrome c was evaluated by subcellular fractionation and immunoblot analysis. To identify and isolate the CSC-like populations, we used the CSC-associated cell surface marker CD44 and flow cytometry. Results: Six out of the 7 gastric cancer cell lines overexpressed Mcl-1 protein. These Mcl-1-expressing cell lines were relatively resistant to chemotherapeutic agents such as 5-fluorouracil (5-FU) and cisplatin (CDDP). Depletion of Mcl-1 protein by RNAi technology effectively sensitized the cells to anticancer drug-induced mitochondrial cytochrome c release, caspase activation, and apoptosis. In addition, vast amounts of Mcl-1 mRNA were expressed in CD44-positive CSC-like cells. Mcl-1 suppression enhanced the apoptosis in CD44-positive cells to a level equivalent to that in CD44-negative cells, suggesting that Mcl-1 mediates chemotherapy resistance in CSC-like populations. Conclusion: These results suggest that Mcl-1 mediates the resistance to apoptosis in gastric cancer cells by blocking the mitochondrial pathway of cell death. Mcl-1 depletion appears to be an attractive strategy to overcome chemotherapy resistance in gastric cancer cells.",
keywords = "Apoptosis, Cancer stem cell, CD44, Chemotherapy resistance",
author = "Hideko Akagi and Hajime Higuchi and Hidetoshi Sumimoto and Toru Igarashi and Ayano Kabashima and Hiroyuki Mizuguchi and Motoko Izumiya and Gen Sakai and Masayuki Adachi and Shinsuke Funakoshi and Shoko Nakamura and Yasuo Hamamoto and Takanori Kanai and Hiromasa Takaishi and Yutaka Kawakami and Toshifumi Hibi",
year = "2013",
month = "1",
doi = "10.1007/s10120-012-0153-6",
language = "English",
volume = "16",
pages = "100--110",
journal = "Gastric Cancer",
issn = "1436-3291",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells

AU - Akagi, Hideko

AU - Higuchi, Hajime

AU - Sumimoto, Hidetoshi

AU - Igarashi, Toru

AU - Kabashima, Ayano

AU - Mizuguchi, Hiroyuki

AU - Izumiya, Motoko

AU - Sakai, Gen

AU - Adachi, Masayuki

AU - Funakoshi, Shinsuke

AU - Nakamura, Shoko

AU - Hamamoto, Yasuo

AU - Kanai, Takanori

AU - Takaishi, Hiromasa

AU - Kawakami, Yutaka

AU - Hibi, Toshifumi

PY - 2013/1

Y1 - 2013/1

N2 - Background: Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic protein that regulates apoptosis sensitivity in a variety of cell types. Here we evaluate the roles of Mcl-1 in chemotherapy-associated apoptosis in gastric cancer cells. In addition, our study examined whether Mcl-1 contributed to apoptosis resistance in so-called cancer stem cell (CSC)-like populations in gastric cancer. Methods: Seven gastric cancer cell lines were used. The expression of Mcl-1 was assessed by either real-time polymerase chain reaction or Western blot analysis. Apoptosis was quantitated by morphological observation and caspase activity measurement. Adenovirus-mediated RNA interference (RNAi) technology was used to knockdown the expression of Mcl-1. The release of cytochrome c was evaluated by subcellular fractionation and immunoblot analysis. To identify and isolate the CSC-like populations, we used the CSC-associated cell surface marker CD44 and flow cytometry. Results: Six out of the 7 gastric cancer cell lines overexpressed Mcl-1 protein. These Mcl-1-expressing cell lines were relatively resistant to chemotherapeutic agents such as 5-fluorouracil (5-FU) and cisplatin (CDDP). Depletion of Mcl-1 protein by RNAi technology effectively sensitized the cells to anticancer drug-induced mitochondrial cytochrome c release, caspase activation, and apoptosis. In addition, vast amounts of Mcl-1 mRNA were expressed in CD44-positive CSC-like cells. Mcl-1 suppression enhanced the apoptosis in CD44-positive cells to a level equivalent to that in CD44-negative cells, suggesting that Mcl-1 mediates chemotherapy resistance in CSC-like populations. Conclusion: These results suggest that Mcl-1 mediates the resistance to apoptosis in gastric cancer cells by blocking the mitochondrial pathway of cell death. Mcl-1 depletion appears to be an attractive strategy to overcome chemotherapy resistance in gastric cancer cells.

AB - Background: Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic protein that regulates apoptosis sensitivity in a variety of cell types. Here we evaluate the roles of Mcl-1 in chemotherapy-associated apoptosis in gastric cancer cells. In addition, our study examined whether Mcl-1 contributed to apoptosis resistance in so-called cancer stem cell (CSC)-like populations in gastric cancer. Methods: Seven gastric cancer cell lines were used. The expression of Mcl-1 was assessed by either real-time polymerase chain reaction or Western blot analysis. Apoptosis was quantitated by morphological observation and caspase activity measurement. Adenovirus-mediated RNA interference (RNAi) technology was used to knockdown the expression of Mcl-1. The release of cytochrome c was evaluated by subcellular fractionation and immunoblot analysis. To identify and isolate the CSC-like populations, we used the CSC-associated cell surface marker CD44 and flow cytometry. Results: Six out of the 7 gastric cancer cell lines overexpressed Mcl-1 protein. These Mcl-1-expressing cell lines were relatively resistant to chemotherapeutic agents such as 5-fluorouracil (5-FU) and cisplatin (CDDP). Depletion of Mcl-1 protein by RNAi technology effectively sensitized the cells to anticancer drug-induced mitochondrial cytochrome c release, caspase activation, and apoptosis. In addition, vast amounts of Mcl-1 mRNA were expressed in CD44-positive CSC-like cells. Mcl-1 suppression enhanced the apoptosis in CD44-positive cells to a level equivalent to that in CD44-negative cells, suggesting that Mcl-1 mediates chemotherapy resistance in CSC-like populations. Conclusion: These results suggest that Mcl-1 mediates the resistance to apoptosis in gastric cancer cells by blocking the mitochondrial pathway of cell death. Mcl-1 depletion appears to be an attractive strategy to overcome chemotherapy resistance in gastric cancer cells.

KW - Apoptosis

KW - Cancer stem cell

KW - CD44

KW - Chemotherapy resistance

UR - http://www.scopus.com/inward/record.url?scp=84872678419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872678419&partnerID=8YFLogxK

U2 - 10.1007/s10120-012-0153-6

DO - 10.1007/s10120-012-0153-6

M3 - Article

C2 - 22527182

AN - SCOPUS:84872678419

VL - 16

SP - 100

EP - 110

JO - Gastric Cancer

JF - Gastric Cancer

SN - 1436-3291

IS - 1

ER -